Cleared Traditional

K992665 - MACRA LP(A) ENZYME IMMUNOASSAY KIT
(FDA 510(k) Clearance)

K992665 · Trinity Biotech USA · Chemistry
Nov 1999
Decision
109d
Days
Class 2
Risk

K992665 is an FDA 510(k) clearance for the MACRA LP(A) ENZYME IMMUNOASSAY KIT, a Lipoprotein, Low-density, Antigen, Antiserum, Control (Class II — Special Controls, product code DFC), submitted by Trinity Biotech USA (Jamestown, US). The FDA issued a Cleared decision on November 26, 1999, 109 days after receiving the submission on August 9, 1999. This device falls under the Chemistry review panel. Regulated under 21 CFR 866.5600.

Submission Details

510(k) Number K992665 FDA.gov
FDA Decision Cleared SESE
Date Received August 09, 1999
Decision Date November 26, 1999
Days to Decision 109 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement

Device Classification

Product Code DFC — Lipoprotein, Low-density, Antigen, Antiserum, Control
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.5600

Similar Devices — DFC Lipoprotein, Low-density, Antigen, Antiserum, Control

All 41
Tina-quant Lipoprotein(a) Gen.2 Molarity
K241220 · Roche Diagnostics Operations · Jan 2025
Lp(a) Ultra
K211058 · SENTINEL CH. SpA · Dec 2022
Diazyme Lipoprotein (a) Assay
K180074 · Diazyme Laboratories, Inc. · Mar 2018
ADVIA CHEMISTRY LIPOPROTEIN(A) REAGENT ADVIA CHEMISTRY LIPOPROTEIN(A) CALIBRATOR
K123046 · Siemens Healthcare Diagnostics, Inc. · Dec 2012
COBAS C TINA-QUANT LIPOPROTEIN (A) GEN 2 ASSAY MODEL 05852625190; PRECISET LP (A) GEN 2 CALIFRATOR SET MODEL 05852641160
K122722 · Roche Diagnostics · Nov 2012
DIAZYME LP(A) ASSAY
K082488 · General Atomics · Jan 2009